Moderna bags another US CDMO to help with fill-finish work for its vaccine amid booster push

Moderna has enlisted another CDMO to ramp up Covid-19 vaccine manufacturing capability in its effort to provide 3 billion doses in 2022.

Starting in Q3, Thermo Fisher Scientific will carry out fill-finish, labeling and packaging services to support Moderna at the CDMO’s Greenville, NC site, the company said in a release.